UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy — Stella

Recruiting

Back to Alzheimer Disease trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

UAB, Birmingham, Alabama

Key details

Phase

Early testing

Sponsor

University of Alabama at Birmingham

Collaborators

National Institute on Aging (NIA)

Enrollment target

~160 participants

Started

July 2020

Primary completion

July 2028

Age range

50 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov